This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. Let’s take a closer look at what DEA data reveals. But despite all the DEA’s seizing and destroying, it’s clear that the average U.S. That’s what DEA data indicates, at least — especially when looked at closely.
The California legislation that would decriminalize some psychedelic substances under state law, Senate Bill 519, was approved in a 5-3 vote by the State Assembly’s Public Safety Committee in a June 29th hearing. Decriminalizing psychedelics is one important step in that direction. They write. Read more at.
Alexandria Ocasio-Cortez (D-NY) called for decriminalizing the use of and research on psychedelics, as well as comprehensive marijuana legalization, in a video message played for a drug policy reform conference on Thursday. Read full report: [link].
. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.
Louis lawmaker behind a recently enacted marijuana decriminalization bill says he’s aware that there’s growing talk about pushing broader reform by loosening laws around psychedelics and other drugs—but he’s concerned that the federal government may intervene if the city pushes the envelope too far. Marijuana Moment report.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S. This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. city to do so.
Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.
Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care.
Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. Study findings indicated that those who had previously taken LSD and psilocybin reported a greater sense of “nature relatedness.”
Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). Decriminalization of Cannabis, Recognition of State law Controlling Cannabis. It would transfer primary agency jurisdiction over cannabis from the DEA to the FDA, TTB, and ATF.
In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. That would be a useful technology in South Dakota. Several northeastern states tried to coordinate their marijuana policies. We predicted (correctly – see below) the Senate’s disinterest here.
According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Nonetheless, with the increasing legalization of medical cannabis, many veterans and interest groups have asked the government to change its policies.
Clinton’s drug policy record while in office has been widely criticized by advocates. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs.
As Canadian legalization has demonstrated, there is a lot of value in both decriminalizing marijuana and profiting from its commodification. . This is partly due to the heavy involvement of the DEA throughout the production process. The biggest change to come out of the recent change was the improved negligence violation policy.
During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. However, the AAFP supports decriminalization of possession of marijuana for personal use. The World Health Organization (WHO) reports approximately 2.5% Call to Action.
The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. Rescheduling cannabis and decriminalizing cannabis do not mean the same thing for federal legalization. The law gives the U.S.
On the other side of the country our nation’s capital has its own ballot initiative on psychedelics, Initiative 81, formally known as the Entheogenic Plant and Fungus Policy Act of 2020. Psilocybin remains a Schedule 1 drug, meaning the DEA says it has a high likelihood of abuse and no accepted medical use – just like marijuana.
7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., DEA and the Controlled Substances Act.
Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”. Number one, I think we should decriminalize marijuana, period. We’re beyond that.”.
As of this writing, cannabis remains a prohibited Schedule 1 drug, defined by the DEA as having “no currently accepted medical use and a high potential for abuse.” . Despite the liberalization of marijuana policies at the state level, the future of federal legalization is hazy. The nearly $100 billion U.S.
The Drug Enforcement Administration (DEA) is currently considering the rescheduling of cannabis from its current Schedule I classification, where it is ranked alongside heroin as an extremely abusive substance. This action aligns with the ongoing efforts for reform.
This bill also directs the DEA to register manufacturers and distributors of CBD or marijuana for commercial production of an approved drug that contains marijuana or its derivative. Additionally, the measure supports federal decriminalization and the release and expungement of any nonviolent, cannabis-only conviction.
As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. While there is no date yet on when the formal decision from the DEA will be released, it could be as soon as a few weeks from now.
Denver has just passed a referendum to decriminalize magic mushrooms. Anslinger was appointed to the Federal Bureau of Narcotics (which later became the DEA) in the 1930’s, leading to his dedicated work in criminalizing all drugs?—?particularly Australia’s preeminent source of cannabis information. And yet, there isn’t anarchy.
cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse at the ever-dynamic global landscape of cannabis policy. Notably, Europe saw significant movement in cannabis policy. As the U.S.
As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.
The Warren-Booker letter , dated October 6, 2021, advocates for DEA to remove cannabis from the federal Controlled Substances Act— which would decriminalize the plant at the federal level. Congressman Earl Blumenauer on federal cannabis law and policy going back to 2017. We’d like to think so.
First, State Senator Jeff Irwin re-introduced a bill that would decriminalize certain psychedelic plants and fungi on a statewide basis. From a policy standpoint, there are pros and cons to this approach. You can find links to stories about both of these items here and here.
Immediately, regulators in other states with newly legalized programs will seek to avoid similar pitfalls while striking an effective regulatory balance: Oregon’s unlimited license policy is an opposite example of what other states yet prefer to avoid. Florida’s marijuana future is showing promise.
Mr. Blumenauer, or “Earl” as he often asked to be called, has been a leading proponent of cannabis reform since 1973, when Oregon was the first state to decriminalize user amounts of the substance. In 2017, Blumenauer was a co-founder of the Congressional Cannabis Caucus , which continues to drive cannabis policy forward today.
Unlike with schedule I narcotics (which are essentially off limits), DEA has very stringent regulations concerning manufacturing, distribution, storage, and prescription of schedule II through V drugs. While many of his contenders wanted decriminalization or even legalization, Biden campaigned on moving marijuana to schedule II.
The Warren-Booker letter , dated October 6, 2021, advocates for DEA to remove cannabis from the federal Controlled Substances Act— which would decriminalize the plant at the federal level. Congressman Earl Blumenauer on federal cannabis law and policy going back to 2017. We’d like to think so.
The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). The DEA limits how much psilocybin can be produced annually, which drives up costs, and the agency imposes other unnecessary burdens on researchers. The first is legislative.
Mace’s bill, while decriminalizing cannabis completely and getting it off of schedule I, would also have the Feds regulate cannabis like alcohol while deferring ultimately to the states on licensing and other commercial regulations. The enforcement role moves from DEA to ATF. ” SBA fairness.
State opt-out- States’ rights would be preserved with the authority of states to set their own marijuana policies and keep it illegal, but states would not be able to stop product from being transported through their state. Petition for resentencing- The bill would allow people currently under a sentence to petition for resentencing.
The membership subsequently met with the USDA’s new Hemp Work Group, and White House officials that serve the President on agriculture and drug control policy. Senators) who joined the group in a spirited, interactive discussion on hemp public policy. The national media took notice of some of the highlights: Rep. By David McGee.
Senior Policy Advisor, Diversion Control Division. The MORE Act would decriminalize marijuana and THC at the federal level by removing it from Schedule I of the Controlled Substances Act, which currently classifies it as an addictive drug that has no accepted medical use, akin to heroin. Drug Enforcement Administration.
Congresswoman Alexandria Ocasio-Cortez, or also known as AOC, pointed out that both sides are coming together on issues concerning civil rights, policy and bringing an end to old drug prohibition laws. . House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. .
Congresswoman Alexandria Ocasio-Cortez, or also known as AOC, pointed out that both sides are coming together on issues concerning civil rights, policy and bringing an end to old drug prohibition laws. . House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. .
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content